Zao-zao Zheng

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo.

A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo.

Journal: Pharmacological research

Published: July 01, 2025

Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs.

Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs.

Journal: Science bulletin

Published: March 30, 2025

Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers.

Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers.

Journal: Molecular & cellular proteomics : MCP

Published: June 12, 2024

Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both In Vitro and In Vivo.

Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both In Vitro and In Vivo.

Journal: Journal of medicinal chemistry

Published: April 03, 2024

CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in Cancer.

CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in Cancer.

Journal: Journal of proteome research

Published: December 12, 2022

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19.

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19.

Journal: Cellular & molecular immunology

Published: June 30, 2022

Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.

Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.

Journal: Nucleic acids research

Published: December 20, 2021

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma.

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 09, 2020

EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.

EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.

Journal: Clinical & translational immunology

Published: January 22, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026